These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 23055838

  • 1. Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
    Rajasingham R, Rolfes MA, Birkenkamp KE, Meya DB, Boulware DR.
    PLoS Med; 2012; 9(9):e1001316. PubMed ID: 23055838
    [Abstract] [Full Text] [Related]

  • 2. Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis.
    Merry M, Boulware DR.
    Clin Infect Dis; 2016 Jun 15; 62(12):1564-8. PubMed ID: 27009249
    [Abstract] [Full Text] [Related]

  • 3. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN.
    Trials; 2018 Nov 23; 19(1):649. PubMed ID: 30470259
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of flucytosine as induction therapy in the treatment of cryptococcal meningitis in HIV-infected adults in South Africa.
    Miot J, Leong T, Takuva S, Parrish A, Dawood H.
    BMC Health Serv Res; 2021 Apr 06; 21(1):305. PubMed ID: 33823842
    [Abstract] [Full Text] [Related]

  • 5. Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis.
    Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman RS, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS.
    Clin Infect Dis; 2020 Jan 01; 70(1):26-29. PubMed ID: 30816418
    [Abstract] [Full Text] [Related]

  • 6. Treatment for HIV-associated cryptococcal meningitis.
    Tenforde MW, Shapiro AE, Rouse B, Jarvis JN, Li T, Eshun-Wilson I, Ford N.
    Cochrane Database Syst Rev; 2018 Jul 25; 7(7):CD005647. PubMed ID: 30045416
    [Abstract] [Full Text] [Related]

  • 7. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D, Dlamini S, Paul N, Dedicoat M.
    Cochrane Database Syst Rev; 2008 Oct 08; (4):CD005647. PubMed ID: 18843697
    [Abstract] [Full Text] [Related]

  • 8. Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.
    Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS, ACTA Trial Study Team.
    N Engl J Med; 2018 Mar 15; 378(11):1004-1017. PubMed ID: 29539274
    [Abstract] [Full Text] [Related]

  • 9. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
    Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS.
    Lancet Infect Dis; 2019 Apr 15; 19(4):e143-e147. PubMed ID: 30344084
    [Abstract] [Full Text] [Related]

  • 10. Treatment of cryptococcal meningitis in resource limited settings.
    Sloan DJ, Dedicoat MJ, Lalloo DG.
    Curr Opin Infect Dis; 2009 Oct 15; 22(5):455-63. PubMed ID: 19587589
    [Abstract] [Full Text] [Related]

  • 11. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    Jarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E, Rutakingirwa MK, Ssebambulidde K, Tugume L, Rhein J, Boulware DR, Mwandumba HC, Moyo M, Mzinganjira H, Kanyama C, Hosseinipour MC, Chawinga C, Meintjes G, Schutz C, Comins K, Singh A, Muzoora C, Jjunju S, Nuwagira E, Mosepele M, Leeme T, Siamisang K, Ndhlovu CE, Hlupeni A, Mutata C, van Widenfelt E, Chen T, Wang D, Hope W, Boyer-Chammard T, Loyse A, Molloy SF, Youssouf N, Lortholary O, Lalloo DG, Jaffar S, Harrison TS, Ambition Study Group.
    N Engl J Med; 2022 Mar 24; 386(12):1109-1120. PubMed ID: 35320642
    [Abstract] [Full Text] [Related]

  • 12. Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.
    Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW, ACTA Trial Team.
    Clin Infect Dis; 2019 Aug 01; 69(4):588-595. PubMed ID: 30863852
    [Abstract] [Full Text] [Related]

  • 13. Cost-effectiveness of single-dose AmBisome pre-emptive treatment for the prevention of cryptococcal meningitis in African low and middle-income countries.
    Rajasingham R, Nalintya E, Israelski DM, Meya DB, Larson BA, Boulware DR.
    Med Mycol; 2022 Feb 01; 60(2):. PubMed ID: 35026017
    [Abstract] [Full Text] [Related]

  • 14. Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.
    Jaruratanasirikul S.
    Southeast Asian J Trop Med Public Health; 1996 Dec 01; 27(4):719-23. PubMed ID: 9253873
    [Abstract] [Full Text] [Related]

  • 15. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, Johnson PC, Tuazon CU, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE.
    N Engl J Med; 1997 Jul 03; 337(1):15-21. PubMed ID: 9203426
    [Abstract] [Full Text] [Related]

  • 16. Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.
    Nussbaum JC, Jackson A, Namarika D, Phulusa J, Kenala J, Kanyemba C, Jarvis JN, Jaffar S, Hosseinipour MC, Kamwendo D, van der Horst CM, Harrison TS.
    Clin Infect Dis; 2010 Feb 01; 50(3):338-44. PubMed ID: 20038244
    [Abstract] [Full Text] [Related]

  • 17. Combination antifungal therapy for cryptococcal meningitis.
    Day JN, Chau TTH, Wolbers M, Mai PP, Dung NT, Mai NH, Phu NH, Nghia HD, Phong ND, Thai CQ, Thai LH, Chuong LV, Sinh DX, Duong VA, Hoang TN, Diep PT, Campbell JI, Sieu TPM, Baker SG, Chau NVV, Hien TT, Lalloo DG, Farrar JJ.
    N Engl J Med; 2013 Apr 04; 368(14):1291-1302. PubMed ID: 23550668
    [Abstract] [Full Text] [Related]

  • 18. Responding to the evidence for improved treatment for cryptococcal meningitis in resource-limited settings.
    Milani B, Ford N.
    S Afr Med J; 2012 Mar 14; 102(4):196-7. PubMed ID: 22464494
    [No Abstract] [Full Text] [Related]

  • 19. Fluconazole and amphotericin B for cryptococcal meningitis.
    Clark AB, Lobo BL, Gelfand MS.
    Ann Pharmacother; 1996 Dec 14; 30(12):1408-10. PubMed ID: 8968453
    [Abstract] [Full Text] [Related]

  • 20. Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in China.
    Zhao T, Xu X, Wu Y, Zhang W, Zeng Q, Lu Y, Yang T, Zhou G, Yu J, Lan K, Harypursat V, Chen Y.
    BMC Infect Dis; 2022 Aug 08; 22(1):677. PubMed ID: 35941618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.